Valence ロゴ
人気
ログイン
Loading data for BNR — first visit, this takes a few seconds.

ウォッチリストに追加

Burning Rock Biotech Limi...

NasdaqGM: BNR · リアルタイム株価 · USD
10.32
+0.62 (6.39%)
終値時点： Aug 24, 2026, 9:30 AM
10.25
-0.68%
時間外: 7:30 PM

株価、主要な数字、最新ニュースをひとまとめにしたページです。

Burning Rock Biotech Limited（BNR）の株価・分析・データ

6.39%
買気配6.35
時価総額108.84M
売上高（TTM）514.43M
純利益（TTM）-59.32M
1.38
-0.88
n/a
-17.79
PBR（TTM）1.42
PSR（TTM）0.21
決算発表日n/a
売気配11.48
出来高1,375
平均出来高（20日）17,861
始値10.32
前日終値9.70
当日レンジ10.32 - 10.32
52週レンジ6.79 - 41.72
アナリストn/a
目標株価n/a
配当n/a
権利落ち日n/a

BNRについて

Burning Rock Biotech Limited develops and sells cancer therapy selection tests in the People's Republic of China and the United States. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company offers next-generation sequencing (NGS)-based tissue, liquid biopsy cancer therapy selection, and prognosis prediction tests for various cancer types, including lung cancer, ...

[続きを読む]
業種 Diagnostics & Research
セクター Healthcare
IPO日 Jun 12, 2020
従業員数 667
上場取引所 NasdaqGM
ティッカー BNR
ウェブサイト https://www.brbiotech.com
企業情報の全文

業績

2025年のBurning Rock Biotechの売上高は539.57Mで、前年の515.82Mから4.6%の増加でした。 利益は-55.35Mで、-84.03%の減少でした。

財務諸表

決算サプライズ

Burning Rock BiotechはMay 30, 2023に四半期決算を発表しました：
  • 売上高は $107.94M で、予想を下回りました $0, うち -18.89% の前年比減少.
  • EPSは -18.1 で、予想を下回りました -4.20, うち 27.60% の前年比増加にあたります.
news image

3週間前 · Simply Wall St.

Myriad Genetics (MYGN) Missed Q2 And Cut Guidance, Is It Still 54% Below Fair Value?

Myriad Genetics (MYGN) is back in focus after its second quarter 2026 earnings missed expectations and the company cut its full year revenue guidance, moves that triggered a sharp selloff in the stock...

news image

3週間前 · Simply Wall St.

Myriad Genetics (MYGN) Is Down 49.0% After Cutting 2026 Revenue Outlook Amid Prenatal Test Weakness

In late July 2026, Myriad Genetics reported second-quarter 2026 results showing sales of US$190.7 million and a reduced net loss of US$43.2 million, while also lowering full-year 2026 revenue guidance...

news image

5か月前 · MarketBeat

Brenntag Q4 Earnings Call Highlights

Brenntag (ETR:BNR) executives said fiscal 2025 played out against one of the most prolonged downturns in the chemical industry in decades, with market conditions deteriorating as the year progressed a...

news image

9か月前 · Barchart

This Undiscovered Biotech Stock Has Quintupled in a Year and Just Hit New Highs

Burning Rock Biotech (BNR) , a precision oncology company from China, has shown exceptional technical momentum and price appreciation. BNR has surged 405% over the past year, hitting a 2-year high on ...